ArticleScientific reports2025
Optimizing co-expression strategies for the simultaneous display and secretion of monoclonal antibodies in CHO cells.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mammalian cell-based dual display and secretion (dualDS) systems enable both surface display of antibodies for binding analysis and simultaneous secretion for functional testing within the same cells. While powerful, their efficiency depends heavily on how light (LC) and heavy chains are co-expressed. In this study, we compared three vector designs in Chinese Hamster Ovary cells: (1) multiple promoters (MP), (2) internal ribosomal entry sites (IRES), and (3) a minimal furin cleavage sequence linked to the 2A peptide (Fm-2A). Vectors were stably integrated into a genomic landing pad using recombinase-mediated cassette exchange. Our results show MP constructs produced heterogeneous expression due to integration errors and transcriptional variability. IRES constructs yielded more homogenous expression but suffered from low secretion due to translational inefficiency. In contrast, the Fm-2A design achieved most uniform antibody display and highest secretion, though residual 2A fragments indicated incomplete furin cleavage. Sequence engineering of Fm-2A improved cleavage efficiency and enhanced antibody quality. These findings underscore the importance of vector design in optimizing dualDS systems and provide a framework for improving library screening, engineering, and other mammalian cell-based applications for therapeutic development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.